David  Pendarvis net worth and biography

David Pendarvis Biography and Net Worth

Insider of ResMed
David Pendarvis was appointed Chief Administrative Officer and Global General Counsel in May 2011. In addition to those roles, he served as Interim President for ResMed’s EMEA and Japan regions from March to August 2017. He joined ResMed as Global General Counsel in September 2002, and has been Corporate Secretary since February 2003. From 2005 to 2011, he served as senior Vice President of Organisational Development.

Before joining ResMed, David was a partner in the law firm Gray Cary Ware & Freidenrich LLP from 2000 to 2002, where he specialised in intellectual property and general business litigation. From 1986 to 2000, he was a partner at Gibson, Dunn & Crutcher LLP. From 1984 to 1986, he was a law clerk to the Hon. J. Lawrence Irving, US District Judge, Southern District of California.

David was elected to the board of directors of WD-40 Company (NASDAQ: WDFC) in December 2017. He has also served on the board of directors of the San Diego Regional Chamber of Commerce since 2013 and the Corporate Directors Forum since 2010. From 2009 to 2016, he was a director on the board of Sequenom, Inc.

David holds a Bachelor of Arts from Rice University; a Juris Doctor (J.D.), cum laude, from the University of Texas School of Law; a Master of Science in executive leadership from the University of San Diego; and a bachelor’s in political science and managerial studies from Rice University.

What is David Pendarvis' net worth?

The estimated net worth of David Pendarvis is at least $905,043.62 as of April 12th, 2024. Mr. Pendarvis owns 4,934 shares of ResMed stock worth more than $905,044 as of April 25th. This net worth approximation does not reflect any other investments that Mr. Pendarvis may own. Learn More about David Pendarvis' net worth.

How do I contact David Pendarvis?

The corporate mailing address for Mr. Pendarvis and other ResMed executives is 9001 SPECTRUM CENTER BLVD., SAN DIEGO CA, 92123. ResMed can also be reached via phone at (858) 836-5000 and via email at [email protected]. Learn More on David Pendarvis' contact information.

Has David Pendarvis been buying or selling shares of ResMed?

David Pendarvis has not been actively trading shares of ResMed during the past quarter. Most recently, David Pendarvis sold 1,500 shares of the business's stock in a transaction on Monday, June 5th. The shares were sold at an average price of $219.79, for a transaction totalling $329,685.00. Following the completion of the sale, the insider now directly owns 89,729 shares of the company's stock, valued at $19,721,536.91. Learn More on David Pendarvis' trading history.

Who are ResMed's active insiders?

ResMed's insider roster includes Carol Burt (Director), Robert Douglas (COO), Karen Drexler (Director), Michael Farrell (CEO), Peter Farrell (Director), Kaushik Ghoshal (Insider), James Hollingshead (Insider), Justin Leong (Insider), David Pendarvis (Insider), Michael Rider (General Counsel), Brett Sandercock (CFO), Rajwant Sodhi (Insider), and Ronald Taylor (Director). Learn More on ResMed's active insiders.

Are insiders buying or selling shares of ResMed?

In the last twelve months, insiders at the medical equipment provider sold shares 25 times. They sold a total of 67,970 shares worth more than $12,960,582.02. The most recent insider tranaction occured on March, 4th when General Counsel Michael J Rider sold 81 shares worth more than $14,580.00. Insiders at ResMed own 1.2% of the company. Learn More about insider trades at ResMed.

Information on this page was last updated on 3/4/2024.

David Pendarvis Insider Trading History at ResMed

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/5/2023Sell1,500$219.79$329,685.0089,729View SEC Filing Icon  
5/3/2023Sell1,500$237.64$356,460.0091,172View SEC Filing Icon  
4/3/2023Sell1,500$218.23$327,345.0092,672View SEC Filing Icon  
3/3/2023Sell1,500$216.69$325,035.0094,172View SEC Filing Icon  
2/3/2023Sell1,500$224.50$336,750.0095,672View SEC Filing Icon  
1/3/2023Sell1,500$210.07$315,105.0097,172View SEC Filing Icon  
12/5/2022Sell1,500$229.81$344,715.0098,672View SEC Filing Icon  
11/3/2022Sell1,545$215.23$332,530.35102,334View SEC Filing Icon  
10/3/2022Sell1,545$220.19$340,193.55103,879View SEC Filing Icon  
8/3/2022Sell1,545$240.72$371,912.40105,286View SEC Filing Icon  
7/5/2022Sell1,545$212.33$328,049.85106,831View SEC Filing Icon  
6/3/2022Sell1,545$209.44$323,584.80108,376View SEC Filing Icon  
5/3/2022Sell1,545$200.00$309,000.00109,858View SEC Filing Icon  
3/3/2022Sell1,544$250.62$386,957.28View SEC Filing Icon  
2/3/2022Sell1,544$232.87$359,551.28View SEC Filing Icon  
12/3/2021Sell1,544$257.93$398,243.92View SEC Filing Icon  
11/3/2021Sell1,485$264.29$392,470.65View SEC Filing Icon  
10/4/2021Sell1,487$260.79$387,794.73View SEC Filing Icon  
9/3/2021Sell1,487$292.16$434,441.92123,959View SEC Filing Icon  
7/6/2021Sell1,487$247.12$367,467.44124,900View SEC Filing Icon  
6/3/2021Sell1,487$207.00$307,809.00View SEC Filing Icon  
4/5/2021Sell1,487$196.15$291,675.05129,294View SEC Filing Icon  
12/3/2020Sell1,487$208.36$309,831.32133,694View SEC Filing Icon  
10/5/2020Sell5,919$170.07$1,006,644.33142,047View SEC Filing Icon  
9/3/2020Sell5,919$177.52$1,050,740.88142,047View SEC Filing Icon  
7/6/2020Sell5,919$194.64$1,152,074.16139,861View SEC Filing Icon  
6/3/2020Sell5,919$160.61$950,650.59136,322View SEC Filing Icon  
5/4/2020Sell4,737$155.06$734,519.22135,379View SEC Filing Icon  
2/3/2020Sell4,739$162.37$769,471.43135,303View SEC Filing Icon  
11/4/2019Sell4,367$147.85$645,660.95128,781View SEC Filing Icon  
10/3/2019Sell4,367$128.62$561,683.54126,618View SEC Filing Icon  
9/3/2019Sell4,367$138.11$603,126.37126,618View SEC Filing Icon  
8/5/2019Sell4,367$128.56$561,421.52122,250View SEC Filing Icon  
7/3/2019Sell4,367$123.86$540,896.62122,250View SEC Filing Icon  
6/3/2019Sell4,367$114.01$497,881.67117,883View SEC Filing Icon  
5/3/2019Sell4,367$112.58$491,636.86View SEC Filing Icon  
4/3/2019Sell4,457$105.21$468,920.97122,459View SEC Filing Icon  
3/4/2019Sell4,457$103.61$461,789.77122,459View SEC Filing Icon  
2/4/2019Sell4,457$93.50$416,729.50View SEC Filing Icon  
11/5/2018Sell2,810$105.97$297,775.70View SEC Filing Icon  
10/3/2018Sell2,810$113.95$320,199.50107,061View SEC Filing Icon  
8/3/2018Sell2,810$106.20$298,422.00101,893View SEC Filing Icon  
6/4/2018Sell2,810$103.75$291,537.50View SEC Filing Icon  
5/3/2018Sell2,810$95.91$269,507.1098,043View SEC Filing Icon  
3/5/2018Sell2,810$94.08$264,364.8097,263View SEC Filing Icon  
2/5/2018Sell2,810$96.03$269,844.3097,263View SEC Filing Icon  
12/4/2017Sell2,804$84.17$236,012.6897,257View SEC Filing Icon  
11/3/2017Sell6,364$82.20$523,120.80View SEC Filing Icon  
10/3/2017Sell6,364$76.94$489,646.16View SEC Filing Icon  
9/5/2017Sell6,364$77.21$491,364.4493,172View SEC Filing Icon  
8/3/2017Sell6,364$72.10$458,844.4084,476View SEC Filing Icon  
7/3/2017Sell6,364$77.36$492,319.0484,476View SEC Filing Icon  
6/5/2017Sell6,365$72.62$462,226.3084,477View SEC Filing Icon  
5/3/2017Sell6,365$69.55$442,685.7584,261View SEC Filing Icon  
4/3/2017Sell6,365$71.59$455,670.3584,261View SEC Filing Icon  
2/3/2017Sell6,365$67.16$427,473.4084,261View SEC Filing Icon  
1/3/2017Sell6,365$61.95$394,311.7584,261View SEC Filing Icon  
12/5/2016Sell6,365$60.00$381,900.0084,261View SEC Filing Icon  
11/3/2016Sell6,033$57.79$348,647.07View SEC Filing Icon  
10/3/2016Sell6,000$63.95$383,700.0087,061View SEC Filing Icon  
9/6/2016Sell6,000$67.18$403,080.0087,061View SEC Filing Icon  
8/3/2016Sell6,000$68.86$413,160.0080,512View SEC Filing Icon  
7/5/2016Sell6,000$63.62$381,720.0080,512View SEC Filing Icon  
6/3/2016Sell6,000$59.41$356,460.0080,512View SEC Filing Icon  
5/3/2016Sell6,000$56.02$336,120.0080,287View SEC Filing Icon  
4/4/2016Sell6,000$58.70$352,200.0080,287View SEC Filing Icon  
3/3/2016Sell6,000$57.26$343,560.0080,287View SEC Filing Icon  
2/3/2016Sell6,000$57.43$344,580.0074,287View SEC Filing Icon  
1/4/2016Sell6,000$52.16$312,960.0074,287View SEC Filing Icon  
12/3/2015Sell6,000$59.38$356,280.0074,287View SEC Filing Icon  
10/5/2015Sell5,500$52.47$288,585.0077,180View SEC Filing Icon  
9/3/2015Sell5,500$51.78$284,790.0077,180View SEC Filing Icon  
7/6/2015Sell5,500$55.19$303,545.00View SEC Filing Icon  
6/3/2015Sell5,500$59.41$326,755.00View SEC Filing Icon  
5/4/2015Sell5,500$65.10$358,050.00View SEC Filing Icon  
4/6/2015Sell5,500$72.60$399,300.00View SEC Filing Icon  
2/5/2015Sell5,500$62.35$342,925.00View SEC Filing Icon  
1/5/2015Sell5,500$57.09$313,995.00View SEC Filing Icon  
11/3/2014Sell3,557$52.00$184,964.00View SEC Filing Icon  
10/3/2014Sell5,000$49.84$249,200.00View SEC Filing Icon  
9/3/2014Sell5,000$53.23$266,150.00View SEC Filing Icon  
8/4/2014Sell5,000$49.12$245,600.00View SEC Filing Icon  
7/3/2014Sell5,000$50.04$250,200.00View SEC Filing Icon  
6/3/2014Sell5,000$49.76$248,800.00View SEC Filing Icon  
4/29/2014Sell15,000$50.01$750,150.0068,956View SEC Filing Icon  
4/4/2014Sell5,000$44.95$224,750.0068,956View SEC Filing Icon  
10/29/2013Sell37,744$50.42$1,903,052.48View SEC Filing Icon  
See Full Table

David Pendarvis Buying and Selling Activity at ResMed

This chart shows David Pendarvis's buying and selling at ResMed by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ResMed Company Overview

ResMed logo
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. It operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. The company was founded in 1989 and is headquartered in San Diego, California.
Read More

Today's Range

Now: $183.43
Low: $179.00
High: $184.30

50 Day Range

MA: $186.31
Low: $173.72
High: $198.04

2 Week Range

Now: $183.43
Low: $132.24
High: $243.52

Volume

1,118,348 shs

Average Volume

1,015,205 shs

Market Capitalization

$26.98 billion

P/E Ratio

30.32

Dividend Yield

1.04%

Beta

0.67